Stoma Ostomy Care Market
| Label | Americas | South-America | United States | Canada |
|---|---|---|---|---|
| 2016 | 403.6 USD Mn | 82.6 USD Mn | 253.3 USD Mn | 67.7 USD Mn |
| 2017 | 446.0 USD Mn | 90.2 USD Mn | 281.6 USD Mn | 74.2 USD Mn |
| 2018 | 456.7 USD Mn | 91.3 USD Mn | 290.1 USD Mn | 75.4 USD Mn |
| 2019 | 467.7 USD Mn | 92.3 USD Mn | 298.8 USD Mn | 76.5 USD Mn |
| 2020 | 478.9 USD Mn | 93.4 USD Mn | 307.9 USD Mn | 77.7 USD Mn |
| 2021 | 491.9 USD Mn | 94.7 USD Mn | 318.1 USD Mn | 79.1 USD Mn |
| 2022 | 505.2 USD Mn | 96.1 USD Mn | 328.6 USD Mn | 80.5 USD Mn |
| 2023 | 519.8 USD Mn | 97.6 USD Mn | 340.2 USD Mn | 82.0 USD Mn |
| 2024 | 534.9 USD Mn | 99.1 USD Mn | 352.2 USD Mn | 83.6 USD Mn |
| 2025 | 550.5 USD Mn | 100.7 USD Mn | 364.6 USD Mn | 85.2 USD Mn |
| 2026 | 567.6 USD Mn | 102.4 USD Mn | 378.2 USD Mn | 87.0 USD Mn |
| 2027 | 585.9 USD Mn | 104.3 USD Mn | 392.8 USD Mn | 88.9 USD Mn |
| 2028 | 606.0 USD Mn | 106.3 USD Mn | 408.7 USD Mn | 91.0 USD Mn |
| 2029 | 628.0 USD Mn | 108.6 USD Mn | 426.0 USD Mn | 93.3 USD Mn |
| 2030 | 652.0 USD Mn | 111.2 USD Mn | 445.0 USD Mn | 95.8 USD Mn |
Data Source: Wantstats Repository
Growth Outlook
- The 2030] by Americas portion of the Global Pompe Disease Treatment market [2016 market is on a steady long-term growth path. Segment value stands at roughly USD 1135 Mn in 2026 and is projected to reach USD 1304 Mn by 2030 — a gain of about 15% over the forecast period, translating to a CAGR in the mid-single digits.
- United States accounted for the largest market share in 2018 in the Americas pompe disease treatment market, and is expected to reach USD 445. 00 Million in 2030 from USD 290.
- What the regional split looks like (2026): Americas leads, holding roughly 50% of segment value — the single largest regional share. United States is the second-largest contributor. South-America and Canada make up the remainder, in descending order.
- By 2030, Americas alone is expected to reach USD 652 Mn, with United States at USD 445 Mn.
Market Dynamics
United States accounted for the largest market share in 2018 in the Americas pompe disease treatment market, and is expected to reach USD 445.00 Million in 2030 from USD 290.10 Million in 2018.This market is projected to grow at a CAGR of 3.69% during the forecast period from 2019 - 2030. enzyme replacement therapy ert segment accounted for the largest market share in 2018, this market is expected to reach USD 457.70 Million in 2030 from USD 323.30 Million in 2018. This market is projected to grow at a CAGR of 3.00% during the forecast period from 2019 - 2030. However, gene therapy segment is the fastest growing market, which is expected to grow at a CAGR of 3.26% during the forecast period 2019 - 2030. late onset pompe disease segment accounted for the largest market share in 2018, this market is expected to reach USD 389.40 Million in 2030 from USD 269.70 Million in 2018. This market is projected to grow at a CAGR of 3.17% during the forecast period from 2019 - 2030.
However, late onset pompe disease segment is the fastest growing market, which is expected to grow at a CAGR of 3.17% during the forecast period 2019 - 2030. hospitals and clinics segment accounted for the larger market share in 2018, this market is expected to reach USD 481.30 Million in 2030 from USD 333.20 Million in 2018. This market is projected to grow at a CAGR of 3.17% during the forecast period from 2019 - 2030. However, hospitals and clinics segment is the fastest growing market, which is expected to grow at a CAGR of 3.17% during the forecast period 2019 - 2030.
Research Methodology
Figures reflect Wantstats’ original market research and forecasting models, compiled as part of the Wantstats research archive and published in 2023.
Unlock the Full Data
Get This Chart
Access the complete chart and underlying data to support your research, analysis, and business decisions.
Powering the world's best teams.
From next-gen startups to established enterprises.
Get in Touch
Let's work together
support@wantstats.comSee our work in action
Start your data driven journey with us!
What our clients say
Trusted by forward-thinking businesses
for data-driven intelligence



